JAMA Surgery : Preoperative Chemotherapy and Radiation for Borderline Resectable Pancreatic Cancer

Interview with Matthew H. G. Katz, MD, author of Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101

Source: JAMA Specialty Journals Author Interviews - June 8, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts